HLA class I antibodies trigger increased adherence of monocytes to endothelial cells by eliciting an increase in endothelial P-selectin and, depending on subclass, by engaging FcγRs.
about
Alloantibody Generation and Effector Function Following Sensitization to Human Leukocyte AntigenThe perfect storm: HLA antibodies, complement, FcγRs, and endothelium in transplant rejectionMHC class I signaling: new functional perspectives for an old moleculeThe divergent roles of macrophages in solid organ transplantationMonocyte recruitment by HLA IgG-activated endothelium: the relationship between IgG subclass and FcγRIIa polymorphisms.Antibody Subclass Repertoire and Graft Outcome Following Solid Organ TransplantationABO-compatible liver allograft antibody-mediated rejection: an update.Role of defensins in the pathogenesis of chronic lung allograft rejection.Complement-Mediated Enhancement of Monocyte Adhesion to Endothelial Cells by HLA Antibodies, and Blockade by a Specific Inhibitor of the Classical Complement Cascade, TNT003Fc receptor inside-out signaling and possible impact on antibody therapy.Platelets in early antibody-mediated rejection of renal transplantsPhosphorylated S6 kinase and S6 ribosomal protein are diagnostic markers of antibody-mediated rejection in heart allografts.Heme Oxygenase-1 Inhibits HLA Class I Antibody-Dependent Endothelial Cell Activation.Endothelial NOTCH1 is suppressed by circulating lipids and antagonizes inflammation during atherosclerosis.An Anti-C1s Monoclonal, TNT003, Inhibits Complement Activation Induced by Antibodies Against HLAMany de novo donor-specific antibodies recognize β2 -microglobulin-free, but not intact HLA heterodimers.Minimizing the risk of allo-sensitization to optimize the benefit of allogeneic cardiac-derived stem/progenitor cells.Donor-specific HLA Antibodies Are Associated With Late Allograft Dysfunction After Pediatric Liver TransplantationAntibodies to HLA Molecules Mimic Agonistic Stimulation to Trigger Vascular Cell Changes and Induce Allograft InjuryInnate immune cells in transplantation.Antibody-mediated graft injury: complement-dependent and complement-independent mechanisms.Graft microvascular disease in solid organ transplantation.Humanized Mouse Models for Transplant Immunology.Functional Immune Anatomy of the Liver-As an Allograft.Label-free detection of immune complexes with myeloid cells.Recent advances in allograft vasculopathy.Not All Antibodies Are Created Equal: Factors That Influence Antibody Mediated Rejection.Antibody-mediated rejection across solid organ transplants: manifestations, mechanisms, and therapies.Inhibition of intimal hyperplasia in murine aortic allografts by administration of a small-molecule TLR4 inhibitor TAK-242.Outside-in HLA class I signaling regulates ICAM-1 clustering and endothelial cell-monocyte interactions via mTOR in transplant antibody-mediated rejection.Five-year histological and serological follow-up of operationally tolerant pediatric liver transplant recipients enrolled in WISP-R.Antigen Presentation by Vascular Cells.The Role of the Endothelium during Antibody-Mediated Rejection: From Victim to Accomplice.Endothelial Dysfunction in Kidney Transplantation.A subset of anti-HLA antibodies induces FcγRIIa-dependent platelet activation
P2860
Q26766411-7956499B-5FDC-4A9F-A1DD-5E0518FD466EQ26862195-F19A8A09-4652-4C3F-B229-7AF0A042F630Q27000194-626A6CE4-3F7C-4829-B69D-D5E9BCAB9BF4Q27022711-734CCA21-5224-4E5D-B230-22D4D8A65A90Q27314948-BF75BD95-208F-43EF-AC3F-2FC7DDC25127Q28076193-60F8C606-57D9-4A12-A64E-63FF90969BE8Q33422561-13803A8F-D6AD-476A-ACBA-F72B976C0AD7Q33570756-FC1782E0-F5B5-4CA5-B3BA-44CAADAF1145Q33829159-FC8589BB-F241-4750-ABE6-515F3D42A6AFQ34499280-8B345CEA-9DA2-490E-9AEC-11DDBBC85794Q35228522-C43101CF-13AE-4FD9-8CE4-485937505C1FQ35469913-628635F5-6D00-4DF8-B760-BE6DD85B886EQ35874401-C9F75F28-7E17-4719-BF25-FC7E7ED4DC59Q36286049-E34585F7-DAD1-4C0F-AF92-F0884E301C5EQ36302476-F9964079-7AFE-4AA1-AC27-5FA65900ABD8Q37352506-4A93C672-14E9-4DAC-9684-C8E248F929E1Q37602004-55980201-F226-4DAD-8FA4-E52949555297Q37616457-49542C71-F609-413B-A16E-E27C7C1906FCQ37720377-49EC3BC2-EB95-4FA1-A819-E16B205B80EFQ38169495-D95735A5-F784-459C-A196-5382859EE939Q38169496-3F934783-2826-41D4-8EB4-A469BEFAFCA0Q38216381-0E37CA0C-5D3C-478C-907F-88B45D959D56Q38640208-4234E7D3-69D7-4BEA-9F08-D425394CD4E8Q38723925-238118DB-FBF9-4FC2-9A8B-FE2D12F623B7Q38787980-53A0B099-8713-4043-BD50-F140F165F7D3Q39023584-F04F5CC2-E415-4254-9F4F-002892E2EAA1Q39217968-9D6A7DBE-1E18-451E-969E-3FE15FF4127AQ39366396-59D45FB9-652B-4545-8418-CD4980902C5BQ45913402-1C6303F1-2844-4749-A540-31B0C12CEFBAQ46258296-0F8965FD-4EED-48E7-B7AB-1F532ADDF0BEQ46516137-969C8406-CAE9-4E31-BCB5-2219B383459EQ49205972-AFD3DFB5-C266-45CF-8FF2-4C6977B975D5Q49521510-2D88A940-73C8-4EEA-BF8E-74F7918AD983Q54983740-58C13A3A-CDDD-4FA9-87D6-B0EED6BE6C50Q58793864-85BC8B1A-71CD-41C3-8254-712771E0F681
P2860
HLA class I antibodies trigger increased adherence of monocytes to endothelial cells by eliciting an increase in endothelial P-selectin and, depending on subclass, by engaging FcγRs.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
HLA class I antibodies trigger ...... n subclass, by engaging FcγRs.
@en
HLA class I antibodies trigger ...... n subclass, by engaging FcγRs.
@nl
type
label
HLA class I antibodies trigger ...... n subclass, by engaging FcγRs.
@en
HLA class I antibodies trigger ...... n subclass, by engaging FcγRs.
@nl
prefLabel
HLA class I antibodies trigger ...... n subclass, by engaging FcγRs.
@en
HLA class I antibodies trigger ...... n subclass, by engaging FcγRs.
@nl
P2093
P2860
P356
P1476
HLA class I antibodies trigger ...... n subclass, by engaging FcγRs.
@en
P2093
Arend Mulder
Elaine F Reed
Nicole M Valenzuela
P2860
P304
P356
10.4049/JIMMUNOL.1201434
P407
P577
2013-05-20T00:00:00Z